Moderate-to-severe atopic dermatitis and systemic corticosteroids are associated with insulin resistance and metabolic syndrome

Berna-Rico, EmilioPérez-Garcia, BibianaGómez-de la Fuente, EnriquePérez-Bootello, JavierAbbad-Jaime de Aragon, CarlotaNeria, FernandoMonge, DianaDomínguez-López, RaquelAranda, Carlos J.Jaen, PedroMehta, Nehal N.Gelfand, Joel M.Blauvelt, AndrewGonzález-Cantero, Álvaro2026-07-312026-07-312026-02Berna-Rico, E, Pérez-Garcia, B, Gómez-de la Fuente, E, Pérez-Bootello, J, Abbad-Jaime de Aragon, C, Neria, F, Monge, D, Domínguez-López, R, Aranda, C J, Jaen, P, Mehta, N N, Gelfand, J M, Blauvelt, A & González-Cantero, Á 2026, 'Moderate-to-severe atopic dermatitis and systemic corticosteroids are associated with insulin resistance and metabolic syndrome', JAAD International, vol. 24, pp. 177-180. https://doi.org/10.1016/j.jdin.2025.09.0212666-3287PubMedCentral: PMC12702370https://hdl.handle.net/10641/81444342973enghttp://creativecommons.org/licenses/by-nc-nd/4.0/atopic dermatitisatopic eczemacomorbiditiescorticosteroidseczemainsulin resistancemetabolic syndromeCorticosteroidsMetabolic syndromeAtopic eczemaComorbiditiesAtopic dermatitisEczemaInsulin resistanceDermatologyJournal ArticleYesModerate-to-severe atopic dermatitis and systemic corticosteroids are associated with insulin resistance and metabolic syndromeLa dermatitis atópica moderada-grave y los corticosteroides sistémicos se asocian con resistencia a la insulina y síndrome metabólico.journal articleopen access10.1016/j.jdin.2025.09.021https://www.scopus.com/pages/publications/105025018188https://www.scopus.com/pages/publications/105025018188#tab=citedBy